A Critical Insight into Primary Open Angle Glaucoma as Jara Vyadhi and its Ayurvedic Interventions: A Single Case Study
DOI:
https://doi.org/10.47552/ijam.v9i3.1116Keywords:
Primary open angle glaucoma; Neuro retino optic nerve degeneration; Intra ocular pressure; Glaucomatous optic neuropathy; Neuro protective adjuvant; Anti glaucoma eye drops.Abstract
Deterioration of vision in elderly people is a major health issue. Currently, the rates of eye disease such as cataract, macular degeneration, diabetic retinopathy and glaucoma are highest in older group. Primary open angle glaucoma is an Insidious and chronic vision - threatening eye aliment due to neuro- retino -optic nerve degeneration, which may be due to raised intra ocular pressure (IOP) or older age or due to independent factors. Classic treatment can delay progression of glaucomatous optic neuropathy by lowering intra ocular pressure (IOP) medically or surgically, but it has its own limitations and interdisciplinary research will be necessary to advance understanding, diagnosis and treatment of this neurodegenerative disease. Main aim of this study is to evaluate the neuro-protective effect of Ayurvedic line of management in primary open angle glaucoma. A multidisciplinary approach from Ayurvedic line of medicine was employed for a diagnosed case of Primary open angle glaucoma (POAG) for 2months. It showed marked improvement in symptoms. This clinical study concludes that Ayurvedic treatment protocol along with Anti glaucoma eye drops are more effective in reducing the intra ocular pressure and control the progression. Hence early diagnosis & proper management can prevent, arrest, OR delay the progression of Primary open angle glaucoma (POAG).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2018 International Journal of Ayurvedic Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.